2019
Spinal Cord Stimulation vs Conventional Therapies for the Treatment of Chronic Low Back and Leg Pain: A Systematic Review of Health Care Resource Utilization and Outcomes in the Last Decade
Odonkor CA, Orman S, Orhurhu V, Stone ME, Ahmed S. Spinal Cord Stimulation vs Conventional Therapies for the Treatment of Chronic Low Back and Leg Pain: A Systematic Review of Health Care Resource Utilization and Outcomes in the Last Decade. Pain Medicine 2019, 20: 2479-2494. PMID: 31498396, DOI: 10.1093/pm/pnz185.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesicsAnalgesics, OpioidChronic PainCosts and Cost AnalysisHealth ExpendituresHealth ResourcesHumansImplantable NeurostimulatorsLegLow Back PainNeurosurgical ProceduresPatient ReadmissionPhysical Therapy ModalitiesProsthesis ImplantationQuality of LifeQuality-Adjusted Life YearsSpinal Cord StimulationConceptsSpinal cord stimulationHealth care resource utilizationChronic low backConventional therapyLeg painCord stimulationComplication rateBack painLow backChronic low back painShorter hospital stayHealth-related qualityHigh complication rateLow complication rateLow back painHealth care costsSports Medicine databaseHospital staySCS therapyChronic painMean ageSCS patientsCT patientsFavorable outcomeInclusion criteria
2017
Is Kratom the New 'Legal High' on the Block?: The Case of an Emerging Opioid Receptor Agonist with Substance Abuse Potential.
Chang-Chien GC, Odonkor CA, Amorapanth P. Is Kratom the New 'Legal High' on the Block?: The Case of an Emerging Opioid Receptor Agonist with Substance Abuse Potential. Pain Physician 2017, 20: e195-e198. PMID: 28072812, DOI: 10.36076/ppj.2017.1.e195.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesics, OpioidAnimalsHumansReceptors, OpioidSubstance Withdrawal SyndromeSubstance-Related DisordersConceptsChronic pain patientsOpioid receptor agonistsPain patientsReceptor agonistPain physiciansAbuse potentialDietary supplementsAlpha-2 adrenergicOpioid replacement therapyNausea/vomitingDelta-opioid receptorsSubstance abuse potentialOpioid withdrawalPain specialistsChronic painPrescription opioidsReplacement therapyPotential deleterious effectsOpioid abuseOpioid overdoseLong-term effectsAnimal studiesSevere signsDrug AdministrationPain literature
2016
What's Tramadol Got to Do with It? A Case Report of Rebound Hypoglycemia, a Reappraisal and Review of Potential Mechanisms.
Odonkor CA, Chhatre A. What's Tramadol Got to Do with It? A Case Report of Rebound Hypoglycemia, a Reappraisal and Review of Potential Mechanisms. Pain Physician 2016, 19: e1215-e1220. PMID: 27906953, DOI: 10.36076/ppj/2016.19.e1215.Peer-Reviewed Original ResearchConceptsAdverse effect profileType 1 diabetes mellitusRebound hypoglycemiaTramadol useMagnetic resonance imagingDiabetes mellitusEffect profileRight buttock painAnalgesic of choiceEpisodes of hypoglycemiaSerotonin uptake inhibitorCounter-regulatory responsePotential mechanismsGlutamate receptor 4Type 1 diabetesSacroiliac joint arthritisButtock painJoint etiologyAntecedent hypoglycemiaJoint arthritisSevere hypoglycemiaLeg discomfortCase reportPhysical examReceptor 4